GILBERTSON RYAN RANDALL 4
4 · Sun BioPharma, Inc. · Filed Dec 15, 2017
Insider Transaction Report
Form 4
GILBERTSON RYAN RANDALL
10% Owner
Transactions
- Exercise/Conversion
Common Stock
2017-12-13$1.88/sh+80,000$150,000→ 567,050 total - Tax Payment
Common Stock
2017-12-13$13.03/sh−11,512$150,001→ 555,538 total - Exercise/Conversion
Warrants (right to buy)
2017-12-13−80,000→ 0 totalExercise: $1.88From: 2015-09-04Exp: 2023-06-04→ Common Stock (80,000 underlying)
Holdings
- 28,000(indirect: By Foundation)
Common Stock
Footnotes (2)
- [F1]Pursuant to "net issue exercise" feature of underlying warrant, represents average closing bid and ask prices of the Issuer's common stock for the ten trading day period ending five trading days prior to December 13, 2017.
- [F2]Unless earlier terminated pursuant to its terms, the warrants terminate upon the earliest of June 2023, upon a closing of a change of control of Issuer, or immediately prior to a closing of a firm commitment underwritten initial public offering pursuant to an effective registration statement filed under the Securities Act covering the offering and sale of Issuer common stock.